We are
Psychedelics Canada

A not-for-profit trade association representing Canadian psychedelic medicine and therapy companies.

About Us

Press Release — Jun. 03, 2022

PSYCHEDELICS CANADA APPLAUDS HEALTH CANADA AND BC GOVERNMENT DECISION TO DECRIMINALIZE POSESSION OF SMALL AMOUNTS OF DRUGS

Read

Press Release — May 27, 2022

PSYCHEDELICS CANADA ANNOUNCES THE LAUNCH OF THE FIRST NATIONAL TRADE ASSOCIATION FOR LEGAL PSYCHEDELICS COMPANIES

Read

News Item — May 20, 2022

PharmaTher Announces Grant of U.S. Patent on Formulation and Production Process of Ketamine and Ketamine Analogs

Read

Psychedelics for mental health care

We champion the benefits of scientifically-proven, psychedelic-assisted therapies administered by qualified practitioners to Canadians suffering from chronic mental health conditions.

Newsroom

Advancing the psychedelics industry

We are dedicated to advocating on behalf of, and improving the regulatory landscape for, the legal psychedelics industry in Canada.

About us

Become a member

We represent researchers, medical practitioners, labs, clinics, drug developers, and suppliers producing and working with psychedelic medicine.

Membership

Leading the
charge for change

Our members are some of Canada’s industry leaders in pharmaceuticals, psychedelics, and mental health research. Together we seek to educate and better understand how psychedelics can improve mental health outcomes and well-being.

More about our members